Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

DBS stock set for Monday spotlight after risk-transfer report; Feb 9 earnings next

DBS stock set for Monday spotlight after risk-transfer report; Feb 9 earnings next

DBS Group Holdings Ltd is considering a move into major risk transfer deals, according to a report in The Straits Times on Friday. The paper referenced Standard Chartered’s $1.5 billion trade-finance transaction set for 2025 and Man Group’s projection that the market could double within five years. Shares of DBS closed at S$57.60, up 0.26 Singapore dollars, or 0.45%. The report noted DBS has held initial talks with funds investing in SRTs—transactions designed to offload part of loan-default risk to investors, often through credit-linked notes. Additionally, DBS is exploring a purchase of up to 30% of Alliance Bank Malaysia, though discussions remain in early stages and the bank declined to comment.
NAB shares slip into the weekend as traders brace for rates, data and the next update

NAB shares slip into the weekend as traders brace for rates, data and the next update

National Australia Bank Ltd shares slipped to A$41.02 on Friday, down 0.2%, as Australia’s major banks all closed lower and the broader market barely budged. The S&P/ASX 200 dipped 0.03%, with ANZ down 0.6%, Westpac off 0.3%, and Commonwealth Bank edging down 0.1%. “There’s no clear directional bias” ahead of key U.S. jobs data, said Capital.com analyst Kyle Rodda. Meanwhile, AMP’s deputy chief economist Diana Mousina pointed to legal risks tied to U.S. tariffs as a near-term factor causing market swings.
11 January 2026
1 285 286 287 288 289 610
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.